Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Irritable Bowel Syndrome
NCT01542268Phase 4Unknown
- Sponsor
- Hospital Universitario de Canarias
- Start
- Mar 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Pentoxifylline with Placebo (2 arms). Primary endpoint: Severity of abdominal pain at 3 months. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01542268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01542268.